10.24
price down icon3.40%   -0.36
after-market Dopo l'orario di chiusura: 10.26 0.02 +0.20%
loading
Precedente Chiudi:
$10.60
Aprire:
$10.69
Volume 24 ore:
4.04M
Relative Volume:
1.01
Capitalizzazione di mercato:
$2.66B
Reddito:
$6.29B
Utile/perdita netta:
$750.00M
Rapporto P/E:
3.5556
EPS:
2.88
Flusso di cassa netto:
$586.00M
1 W Prestazione:
-6.82%
1M Prestazione:
-2.20%
6M Prestazione:
-12.10%
1 anno Prestazione:
-43.43%
Intervallo 1D:
Value
$10.21
$10.77
Intervallo di 1 settimana:
Value
$10.21
$11.29
Portata 52W:
Value
$8.01
$19.05

Organon Co Stock (OGN) Company Profile

Name
Nome
Organon Co
Name
Telefono
551-430-6000
Name
Indirizzo
30 HUDSON STREET, JERSEY CITY
Name
Dipendente
10,000
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
OGN's Discussions on Twitter

Confronta OGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
OGN
Organon Co
10.24 2.76B 6.29B 750.00M 586.00M 2.88
Drug Manufacturers - General icon
LLY
Lilly Eli Co
845.72 756.28B 53.26B 13.80B -50.20M 15.08
Drug Manufacturers - General icon
JNJ
Johnson Johnson
189.69 454.91B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
231.24 411.31B 58.33B 3.73B 18.24B 2.1013
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
132.31 254.66B 53.40B 13.68B 16.89B 6.8864
Drug Manufacturers - General icon
MRK
Merck Co Inc
86.40 218.83B 63.43B 16.42B 14.72B 6.4861

Organon Co Stock (OGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-02 Downgrade Evercore ISI Outperform → In-line
2024-09-06 Downgrade JP Morgan Neutral → Underweight
2023-11-03 Downgrade Goldman Buy → Neutral
2023-09-21 Iniziato Barclays Overweight
2023-03-16 Iniziato Raymond James Outperform
2022-10-14 Downgrade BofA Securities Neutral → Underperform
2022-09-06 Aggiornamento Piper Sandler Neutral → Overweight
2022-08-05 Downgrade BofA Securities Buy → Neutral
2022-04-27 Iniziato Goldman Buy
2022-04-06 Ripresa Morgan Stanley Equal-Weight
2021-10-07 Iniziato Piper Sandler Neutral
2021-09-01 Iniziato BofA Securities Buy
2021-07-22 Iniziato Citigroup Buy
2021-06-15 Iniziato JP Morgan Neutral
2021-06-11 Iniziato Morgan Stanley Equal-Weight
2021-06-10 Iniziato Evercore ISI Outperform
Mostra tutto

Organon Co Borsa (OGN) Ultime notizie

pulisher
07:10 AM

Is There Now Opportunity in Organon Stock After Recent Double Digit Drop in 2025? - Yahoo

07:10 AM
pulisher
09:00 AM

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Yahoo Finance

09:00 AM
pulisher
08:41 AM

Is Organon a Hidden Bargain After Shares Drop Nearly 40% in 2024? - simplywall.st

08:41 AM
pulisher
Oct 06, 2025

Organon (OGN) Stock Slides as Market Rises: Facts to Know Before You Trade - sharewise.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Organon (OGN) Beat Estimates Again in Its Next Earnings Report? - sharewise.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Organon (NYSE:OGN) A Risky Investment? - 富途牛牛

Oct 06, 2025
pulisher
Oct 06, 2025

Is Organon Co a good long term investmentInterest Rate Changes & Advanced Stock Screening Tools - earlytimes.in

Oct 06, 2025
pulisher
Oct 06, 2025

3 Reasons To Avoid OGN And 1 Stock To Buy Instead - Barchart.com

Oct 06, 2025
pulisher
Oct 06, 2025

User - FinancialContent

Oct 06, 2025
pulisher
Oct 05, 2025

Organon (NYSE:OGN) Has No Shortage Of Debt - 富途牛牛

Oct 05, 2025
pulisher
Oct 05, 2025

Organon & Co trades in the red for seven straight sessions - MSN

Oct 05, 2025
pulisher
Oct 03, 2025

Organon & Co. (NYSE:OGN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Co. (7XP) stock good for long term investingJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Organon & Co. $OGN Shares Acquired by Cantor Fitzgerald Investment Advisors L.P. - MarketBeat

Oct 02, 2025
pulisher
Oct 01, 2025

Organon & Co. $OGN Shares Purchased by State of Alaska Department of Revenue - MarketBeat

Oct 01, 2025
pulisher
Sep 30, 2025

AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know - Yahoo

Sep 30, 2025
pulisher
Sep 30, 2025

Co. (7XP) stock in 2025Quarterly Profit Review & Community Driven Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Organon & Co. $OGN Stake Lessened by Sound Income Strategies LLC - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Dakota Wealth Management Has $151,000 Stock Position in Organon & Co. $OGN - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Co. (7XP) stock considered safe havenPortfolio Return Report & AI Enhanced Execution Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Organon (OGN) Outperforms Broader Market: What You Need to Know - sharewise.com

Sep 29, 2025
pulisher
Sep 28, 2025

What analysts say about Organon Co stockReal-Time Stock Alerts & High Return Stock Ideas - Early Times

Sep 28, 2025
pulisher
Sep 28, 2025

Sterneck Capital Management LLC Makes New Investment in Organon & Co. $OGN - MarketBeat

Sep 28, 2025
pulisher
Sep 27, 2025

Register Financial Advisors LLC Sells 30,706 Shares of Organon & Co. $OGN - MarketBeat

Sep 27, 2025
pulisher
Sep 26, 2025

Organon partners across Asia Pacific to push equitable access to contraception ahead of World Contraception Day - MediaBrief

Sep 26, 2025
pulisher
Sep 25, 2025

Here's Why Organon (OGN) Fell More Than Broader Market - sharewise.com

Sep 25, 2025
pulisher
Sep 24, 2025

Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock - sharewise.com

Sep 24, 2025
pulisher
Sep 24, 2025

Organon & Co. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Sep 24, 2025
pulisher
Sep 22, 2025

Wedmont Private Capital Acquires 106,561 Shares of Organon & Co. $OGN - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Organon (OGN): Examining Valuation Following European Approval of Denosumab Biosimilars - simplywall.st

Sep 22, 2025
pulisher
Sep 21, 2025

Organon announces departure of chief commercial officer - MSN

Sep 21, 2025
pulisher
Sep 21, 2025

Gilman Hill Asset Management LLC Sells 443,231 Shares of Organon & Co. $OGN - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

Triumph Capital Management Acquires 47,127 Shares of Organon & Co. $OGN - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Organon (OGN) Stock Dips While Market Gains: Key Facts - sharewise.com

Sep 20, 2025
pulisher
Sep 19, 2025

Organon gets EU approval for Prolia and Xgeva biosimilars - MSN

Sep 19, 2025
pulisher
Sep 19, 2025

Douglas Lane & Associates LLC Raises Holdings in Organon & Co. $OGN - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Organon Q2 Preview: What to expect? - MSN

Sep 19, 2025
pulisher
Sep 19, 2025

Ocugen gets EU approval for Prolia and Xgeva biosimilars - MSN

Sep 19, 2025
pulisher
Sep 19, 2025

Organon (OGN) Gains EU Approval for Denosumab Biosimilars - GuruFocus

Sep 19, 2025
pulisher
Sep 19, 2025

Organon gets EU approval for Prolia and Xgeva biosimilars (OGN:NYSE) - Seeking Alpha

Sep 19, 2025
pulisher
Sep 19, 2025

Organon, Shanghai Henlius: EC approves marketing for Bildyos, Bilprevda - TipRanks

Sep 19, 2025
pulisher
Sep 19, 2025

(denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively - Business Wire

Sep 19, 2025
pulisher
Sep 18, 2025

Belpointe Asset Management LLC Buys New Stake in Organon & Co. $OGN - MarketBeat

Sep 18, 2025
pulisher
Sep 17, 2025

Is Cognition Therapeutics Inc. stock heavily shortedMarket Performance Recap & Reliable Trade Execution Plans - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

WBI Investments LLC Purchases New Stake in Organon & Co. $OGN - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Profit Recap: Should I buy Organon Co stock nowGDP Growth & Low Risk High Win Rate Picks - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Organon & Co. (OGN) Wins FDA Nod for Biosimilars to Prolia and Xgeva - Insider Monkey

Sep 16, 2025

Organon Co Azioni (OGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_general SNY
$48.80
price down icon 0.80%
drug_manufacturers_general PFE
$25.68
price down icon 2.25%
$118.25
price up icon 1.26%
$294.62
price down icon 0.31%
drug_manufacturers_general NVO
$59.61
price up icon 1.00%
drug_manufacturers_general MRK
$86.40
price down icon 1.38%
Capitalizzazione:     |  Volume (24 ore):